Results 191 to 200 of about 3,078,336 (284)

Monitoring of circulating tumor DNA allows early detection of disease relapse in patients with operable breast cancer

open access: yesMolecular Oncology, EarlyView.
Monitoring circulating tumor DNA (ctDNA) in patients with operable breast cancer can reveal disease relapse earlier than radiology in a subset of patients. The failure to detect ctDNA in some patients with recurrent disease suggests that ctDNA could serve as a supplement to other monitoring approaches.
Kristin Løge Aanestad   +35 more
wiley   +1 more source

Supporting the professional development of trial managers: how can you help? [PDF]

open access: yesTrials
Mitchell EJ   +10 more
europepmc   +1 more source

Organisational variation in Recovery College implementation: 31-college qualitative study. [PDF]

open access: yesBJPsych Open
Takhi SK   +21 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy